SLC16A7 and neoplasm: These alternative isoforms of SLC16A7/MCT2 contain identical coding sequences and differ only in their 5′-UTR sequences (Figure 1C), analysis of which revealed key differences in motifs governing translational mechanisms between the isoforms expressed in tumour and benign prostate samples (Figure 1F).